Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Clinical trial NCT04892953 · RECRUITING

Trial details

NCT number: NCT04892953
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Lung Cancer AJCC v8 Stage III Lung Non-Small Cell Cancer AJCC v7 Stage IIIA Lung Cancer AJCC v8 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIB Lung Cancer AJCC v8 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IIIC Lung Cancer AJCC v8

Start date: 2021-07-07
Primary completion: 2026-09-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.